eXIthera Presents Clinical Data on Novel Small Molecule FXIa Inhibitor EP-7041 at American Heart Association
WESTBOROUGH, MA--(Marketwired - Nov 13, 2017) - eXIthera Pharmaceuticals, a clinical stage biotech company focused on discovering and developing effective anticoagulants/antithrombotics without increased bleeding risk or the need for a reversal agent, …